Family size for women with primary ovarian insufficiency and their relatives
- PMID: 37632248
- PMCID: PMC10546072
- DOI: 10.1093/humrep/dead168
Family size for women with primary ovarian insufficiency and their relatives
Abstract
Study question: How does the number of children in women with primary ovarian insufficiency (POI) compare to the number for control women across their reproductive lifespans?
Summary answer: Approximately 14% fewer women with POI will have children, but for those able to have children the median number is 1 less than for age-matched controls.
What is known already: Women with POI are often identified when presenting for fertility treatment, but some women with POI already have children and there remains a low chance for pregnancy after the diagnosis. Further, POI is heritable, but it is not known whether relatives of women with POI have a smaller family size than relatives of controls.
Study design, size, duration: The study was a retrospective case-control study of women with POI diagnosed from 1995 to 2021 (n = 393) and age-matched controls (n = 393).
Participants/materials, setting, methods: Women with POI were identified using ICD9 and 10 codes in electronic medical records (1995-2021) from two major healthcare systems in Utah and reviewed for accuracy. Cases were linked to genealogy information in the Utah Population Database. All POI cases (n = 393) were required to have genealogy information available for at least three generations of ancestors. Two sets of female controls were identified: one matched for birthplace (Utah or elsewhere) and 5-year birth cohort, and a second also matched for fertility status (children present). The number of children born and maternal age at each birth were ascertained by birth certificates (available from 1915 to 2020) for probands, controls, and their relatives. The Mann-Whitney U test was used for comparisons. A subset analysis was performed on women with POI and controls who delivered at least one child and on women who reached 45 years to capture reproductive lifespan.
Main results and the role of chance: Of the 393 women with POI and controls, 211 women with POI (53.7%), and 266 controls (67.7%) had at least one child. There were fewer children born to women with POI versus controls (median (interquartile range) 1 (0-2) versus 2 (0-3); P = 3.33 × 10-6). There were no children born to women with POI and primary amenorrhea or those <25 years old before their diagnosis. When analyzing women with at least one child, women with POI had fewer children compared to controls overall (2 (1-3) versus 2 (2-4); P = 0.017) and when analyzing women who reached 45 years old (2 (1-3) versus 3 (2-4); P = 0.0073). Excluding known donor oocyte pregnancies, 7.1% of women with POI had children born after their diagnosis. There were no differences in the number of children born to relatives of women with POI, including those with familial POI.
Limitations, reasons for caution: The data are limited based on inability to determine whether women were trying for pregnancy throughout their reproductive lifespan or were using contraception. Unassisted births after the diagnosis of POI may be slightly over-estimated based on incomplete data regarding use of donor oocytes. The results may not be generalizable to countries or states with late first births or lower birth rates.
Wider implications of the findings: Approximately half of women with POI will bear children before diagnosis. Although women with POI had fewer children than age matched controls, the difference in number of children is one child per woman. The data suggest that fertility may not be compromised leading up to the diagnosis of POI for women diagnosed at 25 years or later and with secondary amenorrhea. However, the rate of pregnancy after the diagnosis is low and we confirm a birth rate of <10%. The smaller number of children did not extend to relatives when examined as a group, suggesting that it may be difficult to predict POI based on family history.
Study funding/competing interest(s): The work in this publication was supported by R56HD090159 and R01HD099487 (C.K.W.). We also acknowledge partial support for the Utah Population Database through grant P30 CA2014 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no conflicts of interest.
Trial registration number: N/A.
Keywords: birth rate; donor oocyte; heritability; infertility; menopause; primary amenorrhea.
© The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
The authors have no conflicts of interest.
Figures


Similar articles
-
Turner syndrome: fertility, familial clustering, and cancer risk.Hum Reprod. 2025 Feb 1;40(2):391-396. doi: 10.1093/humrep/deae266. Hum Reprod. 2025. PMID: 39658337 Free PMC article.
-
Long-term follow-up to assess criteria for ovarian tissue cryopreservation for fertility preservation in young women and girls with cancer.Hum Reprod. 2023 Jun 1;38(6):1076-1085. doi: 10.1093/humrep/dead060. Hum Reprod. 2023. PMID: 37011633 Free PMC article.
-
Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.Hum Reprod. 2015 Mar;30(3):608-15. doi: 10.1093/humrep/deu353. Epub 2015 Jan 6. Hum Reprod. 2015. PMID: 25567618
-
Health-related quality of life in women with primary ovarian insufficiency: a scoping review of the literature and implications for targeted interventions.Hum Reprod. 2022 Nov 24;37(12):2817-2830. doi: 10.1093/humrep/deac200. Hum Reprod. 2022. PMID: 36102839 Free PMC article.
-
Outcomes after assisted reproductive technology in women with cancer: a systematic review and meta-analysis.Hum Reprod. 2023 Jan 5;38(1):30-45. doi: 10.1093/humrep/deac235. Hum Reprod. 2023. PMID: 36342891 Free PMC article.
Cited by
-
Premature ovarian insufficiency.Nat Rev Dis Primers. 2024 Sep 12;10(1):63. doi: 10.1038/s41572-024-00547-5. Nat Rev Dis Primers. 2024. PMID: 39266563 Review.
-
A Glimpse of Research Trends and Frontiers in the Etiology of Premature Ovarian Insufficiency via Bibliometric Analysis.Endocr Metab Immune Disord Drug Targets. 2025;25(4):310-325. doi: 10.2174/0118715303313887240624071238. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 38919087 Free PMC article. Review.
-
Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency.J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1678-e1686. doi: 10.1210/clinem/dgae480. J Clin Endocrinol Metab. 2025. PMID: 38996041 Free PMC article.
References
-
- Bachelot A, Nicolas C, Bidet M, Dulon J, Leban M, Golmard JL, Polak M, Touraine P.. Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency. Clin Endocrinol (Oxf) 2017;86:223–228. - PubMed
-
- Cambray S, Dubreuil S, Tejedor I, Dulon J, Touraine P.. Family building after diagnosis of premature ovarian insufficiency: a cross-sectional survey in 324 women. Eur J Endocrinol 2023;188:282–289. - PubMed
-
- Fraison E, Crawford G, Casper G, Harris V, Ledger W.. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online 2019;39:467–476. - PubMed
-
- Harris E. A Decade of Declining Fertility in Utah, the Intermountain West, and the Nation: 2010–2020. Kem Gardner Policy Institute, University of Utah, 2021. https://gardner.utah.edu/wp-content/uploads/Fertility-RB-Jul2022.pdf?x71849 (4 May 2023, date last accessed).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials